Respiratory Disposable Market (By Product: Laryngoscope, Tubes, Breathing Bag, Masks, Resuscitator, Others; By Patient Group: Neonatal & Pediatric, Adult, Geriatric; By End User: Hospitals, Nursing Homes, & Clinics, Trauma Centers, Homecare; By Application: Pharmaceuticals, Food & beverages, Cosmetics, Automobiles, Metals, Chemical Companies, Health Sectors, Power generation, Oil and gases and other) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global respiratory disposable market size was USD 2.61 billion in 2023, accounted for USD 2.87 billion in 2024, and is expected to reach around USD 6.66 billion by 2033, expanding at a CAGR of 9.8% from 2024 to 2033.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. respiratory disposable market size was estimated at USD 770 million in 2023 and is predicted to be worth around USD 2,070 million by 2033, at a CAGR of 10.4% from 2024 to 2033.
Market Overview
A respiratory disposable device are the devices used to protect from inhaling vapors, fumes, gases, matters, airborne bacteria’s, viruses present in the environment which may be harmful for the health and infect the body therefore respiratory disposable have increased the growth in the market. Two main types of the respirators are available for example air purifying respirators and air supplied respirators. Air purifying respirators are in which air is obtained by purifying the contaminated particles, air purifying respirator are disposable one time use and at cheap price and air supplied respirators are which supplying of air alternate in respiratory devices different techniques are developed to eliminate the contaminated particles.
Respiratory disposable used in everyday life are disposable mask N-95 the standard mask manufactured used as the respiratory filter. Elastomeric Respirators are having replaceable cartridges. Powered air purifying respirators mostly use pump or fan and they continuously move air through a fitter and give a purified air. Respiratory devices are mostly used in a hospitals by the doctors to perform various operations and surgeries to avoid the infections and majorly used by the chronic infected patients for example asthma, tuberculosis, lung cancer, chronic obstructive pulmonary disease and many other respiratory disease. Respiratory devices are mainly utilized by neonatal, pediatric and adult. Which has raised the use of respiratory device and thrived the market to grow. As per investigation more than 69 million population is undergoing from the chronic respiratory diseases. Moreover 345 million people are suffering from respiratory disease due to increased pollution in the regions and also usage of cigarettes from the individuals which gives tobacco smoke which is hazardous to health. These are the major reasons where respiratory devices used for the healing and for the protection from the air contaminants and improving the growth of the market to grow.
Respirators involve the face piece which covers the mouth, nose, eyes and avoids the entry of contaminants. Respirators are full face forms and half face forms. Full face forms are which covers the full face and half face piece are which covers from nose to mouth. Utilization of respirators are seen in various fields pharmaceutical industries, health sectors, manufacturing companies, defense services, other industries like chemical, metals and mining, oil and gases, agriculture, civil work, power generation, automobile industry usage of the respirators increased in order with the demand of the market as a self-protection which helped to boost the market growth.
Increasing risk of infected virus, spreading of the virus from person to person which improved the demand of the respiratory devices from the market. The positive impact of covid-19 on the respiratory market. Increased hospitalization of the patients due to infected and spreading virus from person to person. Rising demand of the respiratory devices for example pulse oximeters, spirometers, nebulizers, ventilators and the most important requirement oxygen which was decreasing in the corona virus patient. Which has tremendously raised the market growth with the increasing CAGR. Due to shortage of supply of the oxygen and less ventilators number of people have lost their lives.Covid-19 has boosted to grow the respiratory disposable market.
The major growth factor for the respiratory disposable market is increasing due to rising demands from the market and increasing population day by day across the regions. Increasing respiratory diseases in to the regions such as asthma, lung cancer, obstructive pulmonary disease which are driving factors for the growth of the respiratory disposable market.
Asthma is one of the common diseases among the children. As per examination nearly there are 5.3 million of children with asthma below age 18. Increasing number of rate of patients due to increasing pollution and the air contaminants affect hazardously to the individuals. Which led to increased usage of the respiratory devices for the self-protection. Millions of people are suffering from the respiratory disease due to eating tobacco, smoking cigarettes increased pollution which boosted the market for the growth of the respiratory disposable. Improved technologies and development in respiratory disposables with increasing manufacturing of the respiratory disposable. Different advance respiratory technologies developed are 3D technology, Wearable technology and air gel technology. Improved technologies with increased productivity and quality of the product, cheaper rates and readily available, easy to use. Companies are mainly focused on the development and manufacturing of the air gel technology where gel is in the bag and placed on the edges of the mask. Which act as a skin protector and decrease irritation and allergies to the skin.
Due to increasing health awareness among the population have gave rise to increase the market growth rate of respiratory disposable during the forecast period. Because of the rising demand uniformity is maintained by the manufacturing companies for the constant production of the respiratory disposable as per the demand of the market. The standard procedures are imposed for manufacturing and development of the respiratory disposable devices with the good quality and safety with increased productivity.
Respiratory Deposable are majorly utilized in various fields such as Pharmaceutical Industries, health sector in hospitals by the patients and doctors who perform various surgeries and operations and come in contact with various infected patients. Used by the public for the self-protection, oil and gas industries, chemical industries, metal and mining, food and beverages, wood work, automobile company, civil construction work, textile company, defense fighting, agriculture work, forest work. Respiratory devices are used in various sectors for the self-protection are major growth factors which have driven the respiratory disposable market high.
The impact of Covid-19 has expanded the growth of the respiratory disposable market growth due to increasing viruses worldwide and increasing the number of infections across the regions has wide requirement of the respiratory devices such as nebulizers, ventilators, pulse oximeters, mask, air purifying respirators and oxygen therapy has supported for the growth of the market.
Respiratory Disposable Market Scope
Report Coverage | Details |
Market Size in 2023 | USD 2.61 Billion |
Market Size in 2024 | USD 2.87 Billion |
Market Size by 2033 | USD 6.66 Billion |
Growth Rate from 2024 to 2033 | CAGR of 9.8% |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | Product, Patient Group, End User, and Application |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Due to increased demand has increased the revenue market share and imposed standardized guidelines for the development and manufacturing with increased research and development and improved advanced technologies and strategies adopted for the manufacturing and the output of the good productivity and quality of the product and uniformity of manufacturing companies and fulfilling’s the requirement of the market has boosted the respiratory disposable market growth.
On the basis of application respiratory disposable market has wide utilization in various fields. Majorly respiratory devices are used in the hospitals, by the patients with infected disease like asthma, obstructive pulmonary disease, lung cancer and many other respiratory infections used by the doctors in the hospitals during operations and the surgeries performed which has increased the market growth. Usage of the respiratory devices in industries such as food and beverages, pharmaceutical industries, chemical companies, oil and gases, power generation, metals and mining, automobile industries and many more. The development of various new advance technologies has gained the attention of the market and increased growth during the forecast period. Health sector has considerably shown rising peak and increasing economy.
Improved developments of respiratory devices has flawlessly improved the market growth due to increasing demands across the regions. Increasing respiratory disorders among the population has increased the usage of respiratory disposable in the hospitals and among the patients. Usage of the product like laryngoscope, pulse oximeters, breathing bags, tubes, resuscitators, oxygen therapy, masks and many more. It is also used in various companies and industries such as chemical, pharmaceutical industries, metals, oil and gas, power generation, automobile industries and others with improved advance technology helped the market to grow.
Recent Developments
Segments covered in the report
By Product
By Patient Group
By End User
By Application
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Respiratory Disposable Market
5.1. COVID-19 Landscape: Respiratory Disposable Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Respiratory Disposable Market, By Product
8.1. Respiratory Disposable Market, by Product, 2024-2033
8.1.1. Laryngoscope
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Tubes
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Breathing Bag
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Masks
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Resuscitator
8.1.5.1. Market Revenue and Forecast (2021-2033)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Respiratory Disposable Market, By Patient Group
9.1. Respiratory Disposable Market, by Patient Group e, 2024-2033
9.1.1. Neonatal & Pediatric
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Adult
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Geriatric
9.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Respiratory Disposable Market, By End User
10.1. Respiratory Disposable Market, by End User, 2024-2033
10.1.1. Hospitals, Nursing Homes, & Clinics
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Trauma Centers
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Homecare
10.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Respiratory Disposable Market, By Application
11.1. Respiratory Disposable Market, by Application, 2024-2033
11.1.1. Pharmaceuticals
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Pharmaceuticals
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Cosmetics
11.1.3.1. Market Revenue and Forecast (2021-2033)
11.1.4. Automobiles
11.1.4.1. Market Revenue and Forecast (2021-2033)
11.1.5. Metals
11.1.5.1. Market Revenue and Forecast (2021-2033)
11.1.6. Chemical Companies
11.1.6.1. Market Revenue and Forecast (2021-2033)
11.1.7. Health Sectors
11.1.7.1. Market Revenue and Forecast (2021-2033)
11.1.8. Power generation
11.1.8.1. Market Revenue and Forecast (2021-2033)
11.1.9. Oil and gases and other
11.1.9.1. Market Revenue and Forecast (2021-2033)
Chapter 12. Global Respiratory Disposable Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2021-2033)
12.1.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.1.3. Market Revenue and Forecast, by End User (2021-2033)
12.1.4. Market Revenue and Forecast, by Application (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.1.5.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.1.5.3. Market Revenue and Forecast, by End User (2021-2033)
12.1.5.4. Market Revenue and Forecast, by Application (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.1.6.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.1.6.3. Market Revenue and Forecast, by End User (2021-2033)
12.1.6.4. Market Revenue and Forecast, by Application (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.2.3. Market Revenue and Forecast, by End User (2021-2033)
12.2.4. Market Revenue and Forecast, by Application (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.5.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.2.5.3. Market Revenue and Forecast, by End User (2021-2033)
12.2.5.4. Market Revenue and Forecast, by Application (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.6.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.2.6.3. Market Revenue and Forecast, by End User (2021-2033)
12.2.6.4. Market Revenue and Forecast, by Application (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.7.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.2.7.3. Market Revenue and Forecast, by End User (2021-2033)
12.2.7.4. Market Revenue and Forecast, by Application (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.8.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.2.8.3. Market Revenue and Forecast, by End User (2021-2033)
12.2.8.4. Market Revenue and Forecast, by Application (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.3.3. Market Revenue and Forecast, by End User (2021-2033)
12.3.4. Market Revenue and Forecast, by Application (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.5.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.3.5.3. Market Revenue and Forecast, by End User (2021-2033)
12.3.5.4. Market Revenue and Forecast, by Application (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.6.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.3.6.3. Market Revenue and Forecast, by End User (2021-2033)
12.3.6.4. Market Revenue and Forecast, by Application (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.7.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.3.7.3. Market Revenue and Forecast, by End User (2021-2033)
12.3.7.4. Market Revenue and Forecast, by Application (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.8.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.3.8.3. Market Revenue and Forecast, by End User (2021-2033)
12.3.8.4. Market Revenue and Forecast, by Application (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.4.3. Market Revenue and Forecast, by End User (2021-2033)
12.4.4. Market Revenue and Forecast, by Application (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.5.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.4.5.3. Market Revenue and Forecast, by End User (2021-2033)
12.4.5.4. Market Revenue and Forecast, by Application (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.6.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.4.6.3. Market Revenue and Forecast, by End User (2021-2033)
12.4.6.4. Market Revenue and Forecast, by Application (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.7.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.4.7.3. Market Revenue and Forecast, by End User (2021-2033)
12.4.7.4. Market Revenue and Forecast, by Application (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.8.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.4.8.3. Market Revenue and Forecast, by End User (2021-2033)
12.4.8.4. Market Revenue and Forecast, by Application (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.5.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.5.3. Market Revenue and Forecast, by End User (2021-2033)
12.5.4. Market Revenue and Forecast, by Application (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.5.5.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.5.5.3. Market Revenue and Forecast, by End User (2021-2033)
12.5.5.4. Market Revenue and Forecast, by Application (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.5.6.2. Market Revenue and Forecast, by Patient Group (2021-2033)
12.5.6.3. Market Revenue and Forecast, by End User (2021-2033)
12.5.6.4. Market Revenue and Forecast, by Application (2021-2033)
Chapter 13. Company Profiles
13.1. Fisher and Paykel Healthcare
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Smith Group (Smith Medical Inc.)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Hamilton Medical AG
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Getinge AB
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Invacare Corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Masimo Corporation
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Medtronic Plc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Dragerwerk AG and CO. KGAA
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Air liquid S.A
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Chart Industries
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client